Literature DB >> 27344646

The Effect of Multiple Sulfatase Deficiency (MSD) on Dental Development: Can We Use the Teeth as an Early Diagnostic Tool?

Uri Zilberman1,2, Haim Bibi3,4.   

Abstract

BACKGROUND: Multiple sulfatase deficiency (MSD) is a rare autosomal recessive inborn error of metabolism due to reduced catalytic activity of the different sulfatase. Affected individuals show neurologic deterioration with mental retardation, skeletal anomalies, organomegaly, and skin changes as in X-linked ichthyosis. The only organ that was not examined in MSD patients is the dentition.
OBJECTIVES: To evaluate the effect of the metabolic error on dental development in a patient with the intermediate severe late-infantile form of MSD (S155P).
METHODS: Histological and chemical study were performed on three deciduous and five permanent teeth from MSD patient and pair-matched normal patients.
RESULTS: Tooth germ size and enamel thickness were reduced in both deciduous and permanent MSD teeth, and the scalloping feature of the DEJ was missing in MSD teeth causing enamel to break off from the dentin. The mineral components in the enamel and dentin were different.
CONCLUSIONS: The metabolic error insults the teeth in the stage of organogenesis in both the deciduous and permanent dentition. The end result is teeth with very sharp cusp tips, thin hypomineralized enamel, and exposed dentin due to the break off of enamel. These findings are different from all other types of MPS syndromes.Clinically the phenotype of intermediate severe late-infantile form of MSD appeared during the third year of life. In children of parents that are carriers, we can diagnose the disease as early as birth using X-ray radiograph of the anterior upper region or as early as 6-8 months when the first deciduous tooth erupt and consider very early treatment to ameliorate the symptoms.

Entities:  

Year:  2016        PMID: 27344646      PMCID: PMC5110438          DOI: 10.1007/8904_2015_523

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  17 in total

1.  SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency.

Authors:  Lars Schlotawa; Eva Charlotte Ennemann; Karthikeyan Radhakrishnan; Bernhard Schmidt; Anupam Chakrapani; Hans-Jürgen Christen; Hugo Moser; Beat Steinmann; Thomas Dierks; Jutta Gärtner
Journal:  Eur J Hum Genet       Date:  2011-01-12       Impact factor: 4.246

2.  Studies on the proteins of developing bovine enamel.

Authors:  M Fukae; M Shimizu
Journal:  Arch Oral Biol       Date:  1974-05       Impact factor: 2.633

3.  Oral findings in metachromatic leukodystrophy.

Authors:  D G Gardner; W Zeman
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1970-03

4.  Unusual clinical presentation in two cases of multiple sulfatase deficiency.

Authors:  M E Blanco-Aguirre; S H Kofman-Alfaro; M R Rivera-Vega; C Medina; M Valdes-Flores; W B Rizzo; S A Cuevas-Covarrubias
Journal:  Pediatr Dermatol       Date:  2001 Sep-Oct       Impact factor: 1.588

5.  Prenatal growth acceleration in maxillary deciduous canines of children with Down syndrome: histological and chemical composition study.

Authors:  David Keinan; Patricia Smith; Uri Zilberman
Journal:  Arch Oral Biol       Date:  2007-06-13       Impact factor: 2.633

6.  Molecular analysis of SUMF1 mutations: stability and residual activity of mutant formylglycine-generating enzyme determine disease severity in multiple sulfatase deficiency.

Authors:  Lars Schlotawa; Robert Steinfeld; Kurt von Figura; Thomas Dierks; Jutta Gärtner
Journal:  Hum Mutat       Date:  2008-01       Impact factor: 4.878

7.  Enamelysin (matrix metalloproteinase 20)-deficient mice display an amelogenesis imperfecta phenotype.

Authors:  John J Caterina; Ziedonis Skobe; Joanne Shi; Yanli Ding; James P Simmer; Henning Birkedal-Hansen; John D Bartlett
Journal:  J Biol Chem       Date:  2002-10-21       Impact factor: 5.157

8.  Clinical findings in 12 patients with MPS IV A (Morquio's disease). Further evidence for heterogeneity. Part II: Dental findings.

Authors:  J Nelson; M Kinirons
Journal:  Clin Genet       Date:  1988-02       Impact factor: 4.438

9.  Oral manifestations of 17 patients affected with mucopolysaccharidosis type VI.

Authors:  Piranit Nik Kantaputra; Hülya Kayserili; Yeliz Güven; Warissara Kantaputra; Mehmet C Balci; Pranoot Tanpaiboon; Anusha Uttarilli; Ashwin Dalal
Journal:  J Inherit Metab Dis       Date:  2013-08-22       Impact factor: 4.982

Review 10.  Dental enamel development: proteinases and their enamel matrix substrates.

Authors:  John D Bartlett
Journal:  ISRN Dent       Date:  2013-09-16
View more
  4 in total

1.  Complex care of individuals with multiple sulfatase deficiency: Clinical cases and consensus statement.

Authors:  Rebecca Ahrens-Nicklas; Lars Schlotawa; Andrea Ballabio; Nicola Brunetti-Pierri; Mauricio De Castro; Thomas Dierks; Florian Eichler; Can Ficicioglu; Alan Finglas; Jutta Gaertner; Brian Kirmse; Joerg Klepper; Marcus Lee; Amber Olsen; Giancarlo Parenti; Arastoo Vossough; Adeline Vanderver; Laura A Adang
Journal:  Mol Genet Metab       Date:  2018-01-31       Impact factor: 4.797

2.  Multiple Sulfatase Deficiency (MSD): Review of the Literature and Case Reports of Two Siblings with Dental Caries and Trauma.

Authors:  Lorna Hirst; Gehan Abou-Ameira; Mari-Liis Uudelepp
Journal:  Case Rep Pediatr       Date:  2021-02-16

Review 3.  Multiple Sulfatase Deficiency: A Disease Comprising Mucopolysaccharidosis, Sphingolipidosis, and More Caused by a Defect in Posttranslational Modification.

Authors:  Lars Schlotawa; Laura A Adang; Karthikeyan Radhakrishnan; Rebecca C Ahrens-Nicklas
Journal:  Int J Mol Sci       Date:  2020-05-13       Impact factor: 5.923

4.  A homozygous missense variant of SUMF1 in the Bedouin population extends the clinical spectrum in ultrarare neonatal multiple sulfatase deficiency.

Authors:  Orna Staretz-Chacham; Lars Schlotawa; Ohad Wormser; Inbal Golan-Tripto; Ohad S Birk; Carlos R Ferreira; Thomas Dierks; Karthikeyan Radhakrishnan
Journal:  Mol Genet Genomic Med       Date:  2020-02-12       Impact factor: 2.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.